Today's Must Read
BP Banks on Key Upstream Projects, Refining Weak
Digital Moves Aid Fidelity (FIS), Intense Competition Hurts
Thursday, January 2, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), BP p.l.c. (BP) and Fidelity National Information Services (FIS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Pfizer’s shares have underperformed the Zacks Large-Cap Pharmaceuticals industry over the past year (-6.8% vs. +14.8%). The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo, the Array acquisition and the pending merger of Upjohn unit with Mylan, if successful, will make Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
The smaller Pfizer should see better revenue growth as the Lyrica LOE cliff will go away. The company expects continued strong growth of key brands like Ibrance, Xeljanz and Eliquis to drive sales in the coming quarters. Pfizer is also strengthening its pipeline and hopes to launch new innovative medicines in the next five years, which can drive long-term growth.
However, Lyrica generic erosion, currency headwinds and pricing pressure are key near-term, top-line headwinds. Estimates have remained stable ahead of Q4 earnings release. Pfizer has a positive record of earnings surprises in the recent quarters.
Shares of BP have gained +3.7% in the past three months against the Zacks International Integrated Oil industry’s rise of +4.6%. The Zacks analyst believes that BP has been benefiting from a strong portfolio of upstream projects. Since 2016, the British energy giant has placed 23 major upstream projects online.
All the key projects BP has been delivering over the years backed the company to post record production levels. These projects will also help the firm boost production by 900 Mboe/d within 2021. Moreover, BP plans to boost spending on renewable power business as most European firms have decided to combat climate change.
However, the 2010 oil-spill incident in the BP-operated Macondo Prospect is still affecting the company. Although it cleared the huge litigation expenses related to the spill, it had to divest some of its best operating properties. Also, the company expects refining margins in the December quarter of 2019 to drop sequentially due to continued turnaround activities.
Fidelity National Information Services' shares have gained +9.8% over the past six months against the Zacks Financial Transaction Services industry's rise of +5.5%. The Zacks analyst believes that the company remains well positioned for growth backed by its attractive core business with a recurring revenue model, digitization, and several ongoing strategic initiatives.
Fidelity’s deal to acquire Worldpay is likely to accelerate its growth by boosting presence in faster growing markets. Also, the transaction will provide synergies of $700 million from revenue and cost management over next three years. However, the company remains exposed to consolidation in the banking sector and significant competition from new entrants. Also, unsustainable capital deployment activities of the company remain a concern.
Other noteworthy reports we are featuring today include Deere & Company (DE), Occidental Petroleum (OXY) and Equity Residential (EQR).
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>